Ourotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-10
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ourotech.ca
Clinical Trials
4
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
Not yet recruiting
- Conditions
- Renal Cell Cancer MetastaticKidney Cancer
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Ourotech, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06264479
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
🇬🇧Mount Vernon Cancer Centre, London, United Kingdom
🇬🇧Imperial College Healthcare NHS Trust, London, United Kingdom
Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)
Recruiting
- Conditions
- Breast CancerTriple Negative Breast Cancer
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Ourotech, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06182306
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧Barts Hospital NHS Trust, London, United Kingdom
🇬🇧Guys and St. Thomas Hospital NHS Trust, London, United Kingdom
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Recruiting
- Conditions
- EpendymomaBrain TumorOligodendrogliomaGlioblastomaGlioma, Malignant
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Ourotech, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06038760
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment
Recruiting
- Conditions
- Triple Negative Breast CancerTriple Negative Breast Neoplasms
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Ourotech, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05435352
- Locations
- 🇬🇧
Barts Health NHS Trust, London, United Kingdom
🇬🇧The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧Manchester University NHS, Manchester, United Kingdom
News
No news found